Joe DeSimone, director of UNC-Chapel Hill's Frank Hawkins Kenan Institute of Private Enterprise, kicked off the UNC Eshelman School of Pharmacy’s Board of Visitors meeting today (Nov. 13) with keynote remarks on the role of research intensive universities in entrepreneurship.
DeSimone is professor of chemistry at the University of North Carolina at Chapel Hill, professor of chemical engineering at N.C. State University and an adjunct member at Memorial Sloan-Kettering Cancer Center. He holds more than 130 issued patents in his name and more than 80 patents pending. In 2004, he launched Liquidia Technologies, which has raised more than $60 million in venture financing, including the first-ever equity investment by the Bill and Melinda Gates Foundation in a for-profit biotech company.
DeSimone’s research group focuses on harnessing the fabrication technologies from the semiconductor industry to design high-performance, cost-effective vaccines and medicines. He is a member of both the National Academy of Sciences and National Academy of Engineering.
The Kenan Institute, part of the UNC-Chapel Hill’s Kenan-Flagler Business School, pursues cutting-edge research, educational programs and public policy initiatives in the areas of entrepreneurship, economic development and global competitiveness. For more information, visit www.kenaninstitute.unc.edu or call (919) 962-8201.